Larvol Delta - Second-Quarter-2026-and-Subsequent-Period-Highlights

Stalaris (efzofitimod) - aTyr Pharma, Kyorin

https://www.manilatimes.net/2026/08/08/tmt-newswire/globenewswire/atyr-pharma-announces-second-quarter-2026-results-program-prioritization-and-corporate-restructuring-to-support-efzofitimod-program-in-ild/2401225

Aug 8, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Next